Review highlights advances in rhamnogalacturonan-II biosynthesis and dimerization in plants, revealing mechanisms controlling cell wall architecture.
Despite its low abundance, rhamnogalacturonan-II (RG-II) is an essential structural component of the cell wall and is present in a highly conserved molecular configuration across all plants. RG-II is a branched pectin domain that contains 13 different sugars linked by over 20 different bond types, and uniquely among pectins it can be covalently dimerized via borate diesters. RG-II is hypothesized to crosslink the pectin matrix, controlling cell wall architecture and porosity, but has resisted detailed analyses due to its compositional complexity and the lethality of RG-II-deficient mutants. Here, we highlight how biochemical dissection, genetic engineering, chemical inhibitors, and high-resolution imaging have enabled recent leaps in our understanding of RG-II structure, synthesis, localization, dimerization, and function, pointing out new questions and research directions that have been enabled by these advances.
No takes yet. Share an insight, caveat, or question.
Hays et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: